CDSCO says Indian hospital charged for stem cell treatments given during unapproved trial

By Gareth Macdonald

- Last updated on GMT

Related tags Good clinical practice

Chaitanya Hospital, Pune India
Chaitanya Hospital, Pune India
Indian regulators have accused a hospital of conducting unauthorised clinical trials of stem cell therapies and of charging patients who took part for the treatments.

The Central Drugs Standard Control Organization (CDSCO) launched its investigation of Chaitanya Hospital in Pune in November after reports that unapproved cell therapies were being offered to patients with cerebral palsy, stroke, Wilson’s disease and spinal cord injury in unauthorised clinical trials.

According to a letter sent​ to the hospital on November 21, the CDSCO investigation confirmed the reports and said that – in addition to failing to gain approval – the institution had also broken good clinical practices (GCP) regulations.

Specific infractions included that the hospital lacks the equipment needed to process the bone marrow derived cells in an aseptic manner despite its claim they were handled under "minimum manipulation category as per ICMR [Indian Council of Medical Research] guidelines."

The CDSCO added that: “No documents were maintained as required under Good Clinical Practices and moreover patients were charged heavily for the treatment for period 2013 to Sep 2014​.”

The regulator ordered Chaitanya Hospital to halt the trials with immediate effect in a follow up letter sent earlier this month.

Representatives for Chaitanya Hospital did not respond to Outsourcing-pharma.com’s request for comment ahead of publication.

The hospital is listed as the site of several stem cell studies on the Indian Clinical Trial Registry (here​).

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers

Follow us

Products

View more

Webinars